These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
846 related items for PubMed ID: 28193220
1. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia. Arai R, Onodera T, Terkawi MA, Mitsuhashi T, Kondo E, Iwasaki N. BMC Musculoskelet Disord; 2017 Feb 13; 18(1):79. PubMed ID: 28193220 [Abstract] [Full Text] [Related]
2. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature. Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y. Chin J Cancer; 2011 Nov 13; 30(11):794-804. PubMed ID: 22035861 [Abstract] [Full Text] [Related]
3. Tumor-induced osteomalacia: experience from a South American academic center. González G, Baudrand R, Sepúlveda MF, Vucetich N, Guarda FJ, Villanueva P, Contreras O, Villa A, Salech F, Toro L, Michea L, Florenzano P. Osteoporos Int; 2017 Jul 13; 28(7):2187-2193. PubMed ID: 28341900 [Abstract] [Full Text] [Related]
4. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients. Zuo QY, Wang H, Li W, Niu XH, Huang YH, Chen J, You YH, Liu BY, Cui AM, Deng W. BMC Musculoskelet Disord; 2017 Sep 21; 18(1):403. PubMed ID: 28934935 [Abstract] [Full Text] [Related]
5. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt. Seemann L, Padala SA, Mohammed A, Belayneh N. J Investig Med High Impact Case Rep; 2019 Sep 21; 7():2324709619895162. PubMed ID: 31850815 [Abstract] [Full Text] [Related]
6. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature. Kojima D, Ohba S, Abe M, Suzuki A, Horibe S, Tateya I, Hasegawa M, Hirose Y. Neuropathology; 2022 Oct 21; 42(5):453-458. PubMed ID: 35880350 [Abstract] [Full Text] [Related]
7. A Rare Association Between Osteomalacia, Phosphaturic Mesenchymal Tumor, and Ovarian Cancer: A Case Report and Literature Review. Mazza M, Arcidiacono GP, Hoxhaj I, Padoan V, Tasca G, Burei M, Sella S, Simioni P, Giannini S, Mocellin S. Calcif Tissue Int; 2024 Aug 21; 115(2):196-203. PubMed ID: 38806758 [Abstract] [Full Text] [Related]
9. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report. Ryhänen EM, Schalin-Jäntti C, Matikainen N. Front Endocrinol (Lausanne); 2021 Jul 13; 12():686135. PubMed ID: 34149623 [Abstract] [Full Text] [Related]
10. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation. Horng JC, Van Eperen E, Tutton S, Singh R, Shaker JL, Wooldridge AN. Osteoporos Int; 2021 Sep 13; 32(9):1895-1898. PubMed ID: 33655402 [Abstract] [Full Text] [Related]
11. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report. Kim I, Rajani R. J Foot Ankle Surg; 2016 Sep 13; 55(2):294-8. PubMed ID: 25441266 [Abstract] [Full Text] [Related]
12. Phosphaturic Mesenchymal Tumor Along the Hallux side Inducing a Chronic non-Healing Wound: A Case Report with Literature Review. Sun X, Ni P, Xie T, Wu S. Int J Low Extrem Wounds; 2023 Dec 13; 22(4):779-787. PubMed ID: 35043721 [Abstract] [Full Text] [Related]
14. Reports of 17 Chinese patients with tumor-induced osteomalacia. Yu WJ, He JW, Fu WZ, Wang C, Zhang ZL. J Bone Miner Metab; 2017 May 13; 35(3):298-307. PubMed ID: 27085966 [Abstract] [Full Text] [Related]
15. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis. Fathalla H, Cusimano M, Di Ieva A, Karamchandani J, Fung R, Kovacs K. World Neurosurg; 2015 Jul 13; 84(1):189.e1-5. PubMed ID: 25746588 [Abstract] [Full Text] [Related]
16. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes. Dutta D, Pandey RK, Gogoi R, Solanki N, Madan R, Mondal A, Dogra S, Thapa P. Endokrynol Pol; 2018 Jul 13; 69(2):205-210. PubMed ID: 29442350 [Abstract] [Full Text] [Related]
17. Phosphaturic mesenchymal tumors: what an endocrinologist should know. Boland JM, Tebben PJ, Folpe AL. J Endocrinol Invest; 2018 Oct 13; 41(10):1173-1184. PubMed ID: 29446010 [Abstract] [Full Text] [Related]
18. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed? Ledford CK, Zelenski NA, Cardona DM, Brigman BE, Eward WC. Clin Orthop Relat Res; 2013 Nov 13; 471(11):3618-25. PubMed ID: 23868423 [Abstract] [Full Text] [Related]
19. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, Ranchere-Vince D, Decouvelaere AV, de la Fouchardiere A, Gill AJ. Hum Pathol; 2013 Dec 13; 44(12):2711-8. PubMed ID: 24060005 [Abstract] [Full Text] [Related]
20. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature. Mori Y, Ogasawara T, Motoi T, Shimizu Y, Chikazu D, Tamura K, Fukumoto S, Takato T. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar 13; 109(3):e57-63. PubMed ID: 20219587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]